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Abstract
Background: Brown and white adipose tissues (BAT and WAT) play critical roles in controlling energy homeostasis
and in the development of obesity and diabetes. The mouse Fat-Specific protein 27 (FSP27), a member of the cell
death-inducing DFF45-like effector (CIDE) family, is expressed in both BAT and WAT and is associated with lipid
droplets. Over-expression of FSP27 promotes lipid storage, whereas FSP27 deficient mice have improved insulin
sensitivity and are resistant to diet-induced obesity. In addition, FSP27-deficient white adipocytes have reduced lipid
storage, smaller lipid droplets, increased mitochondrial activity and a higher expression of several BAT-selective
genes. To elucidate the molecular mechanism by which FSP27 controls lipid storage and gene expression in WAT
and BAT, we systematically analyzed the gene expression profile of FSP27-deficient WAT by microarray analysis and
compared the expression levels of a specific set of genes in WAT and BAT by semi-quantitative real-time PCR analysis.
Results: BAT-selective genes were significantly up-regulated, whereas WAT-selective genes were down-regulated in
the WAT of FSP27-deficient mice. The expression of the BAT-selective genes was also dramatically up-regulated in the
WAT of leptin/FSP27 double deficient mice. In addition, the expression levels of genes involved in multiple metabolic
pathways, including oxidative phosphorylation, the TCA cycle, fatty acid synthesis and fatty acid oxidation, were
increased in the FSP27-deficient WAT. In contrast, the expression levels for genes involved in extracellular matrix
remodeling, the classic complement pathway and TGF-b signaling were down-regulated in the FSP27-deficient WAT.
Most importantly, the expression levels of regulatory factors that determine BAT identity, such as CEBPa/b, PRDM16
and major components of the cAMP pathway, were markedly up-regulated in the WAT of FSP27-deficient mice. The
expression levels of these regulatory factors were also up-regulated in leptin/FSP27 double deficient mice.
Interestingly, distinct gene expression profiles were observed in the BAT of FSP27-deficient mice. Taken together,
these data suggest that the WAT of FSP27-deficient mice have a gene expression profile similar to that of BAT.
Conclusions: FSP27 acts as a molecular determinant that controls gene expression for a diversity of metabolic and
signaling pathways and, in particular, the expression of regulatory factors, including CEBPa/b, PRDM16 and
components of the cAMP signaling pathway, that control the identity of WAT and BAT.
Background
Adipose tissues play crucial roles in the development of
obesity, with white adipose tissue (WAT) functioning as
an energy storage organ and brown adipose tissue (BAT)
functioning as an energy consumption organ [1]. BAT is
especially abundant throughout the life-span of rodents
and in hibernating mammals. In humans it was believed to
present only in newborns and disappears in adults [2,3].
Interestingly, BAT and its increased activities in response
to low temperature (16°C) can be detected in adult
humans by
18F-fluorodeoxyglucose (
18F-FDG) positron-
emission tomography-computed tomography (PET-CT),
and the response negatively correlates with their increas-
ing body mass index [4-6]. Although WAT and BAT both
express a set of genes that are involved in the regulation of
lipolysis, fatty acid metabolism, triacylglycerol (TAG) sto-
rage and insulin sensitivity [7,8], BAT contains a large
number of mitochondria and is functionally more impor-
tant as a thermogenic tissue [9]. Uncoupling protein 1
(UCP1), which is uniquely expressed in BAT, plays an
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any medium, provided the original work is properly cited.important role in the uncoupling of oxidative phosphory-
lation and the conversion of energy into heat to maintain
normal body temperature. In addition to UCP1, type 2
iodothyronine deiondinase (DIO2) [10], elongation of very
long chain fatty acid-3 (ELOVL3) [11-13], COX8b [14,15]
and lipid storage droplet protein 5 (LSDP5) [16-18] are
also expressed at high levels in BAT but low levels in
WAT. PGC-1a [19,20], a co-activator that coordinates
multiple physiological cues for mitochondrial biogenesis
and activity, is highly expressed in BAT but only expressed
at low levels in WAT [21]. TR3, a member of the nuclear
receptor super-family, is expressed in brown adipocytes
upon cold exposure and inhibits adipocyte differentiation
[22,23]. In contrast, mesoderm-specific transcript (MEST)
gene expression is markedly enhanced in the WAT of
mice with diet-induced and genetically caused obesity
[24]. Its expression levels are positively correlated with
white fat mass, which may be related to its putative lipase
activity [25]. Resistin-like molecule alpha (RETNLa),
which shares homology with Resistin [26,27], has also
been shown to be exclusively expressed in the stromal vas-
cular fraction of WAT [28].
The exact origin of brown and white adipocytes and
their developmental relationship is not clear. Brown and
white adipocytes were previously considered to be
derived from a common preadipocyte pool [29]. How-
ever, recent studies have suggested instead that brown
adipocytes and muscle cells share a similar precursor,
based on the observation that knock-down of PRDM16,a
BAT-specific gene [15,30], switched the fate of brown
adipocytes to that of muscle cells [31]. PRDM16 appears
to be a co-factor for CEBPb and PGC1a/b, which up-reg-
ulates the expression of many BAT-selective genes while
down-regulating the expression of WAT-selective genes
[15,32]. Differentiated WAT is able to develop a BAT-
like phenotype under special conditions including cold
exposure or after the administration of a b3-agonist to
WAT depots [33-35]. PPARg has been shown to be
required for the conversion of WAT to a BAT-like tissue
based on the observation that this conversion is blocked
in cold-acclimatized PPARg-mutant (P465L) mice [36].
Over-expression of the CEBPb gene in CEBPa-deficient
mice results in increased expression of the Gsa subunit,
enhanced mitochondrial biogenesis and increased UCP1
expression in WAT [37]. The WAT in mice over-expres-
sing FOXC2 is converted into a BAT-like tissue with a
corresponding increase in the expression levels of PGC1,
UCP1 and cAMP pathway proteins [38]. Although many
factors and regulatory pathways have been shown to play
important roles in regulating the conversion of WAT to
at i s s u ew i t haB A T - l i k ep h e n o t y p ea n df u n c t i o n ,t h e
upstream signals or factors that determine the fate of
BAT vs. WAT and initiate the conversion of WAT to a
BAT-like tissue remain unclear.
CIDE proteins, including CIDEA, CIDEB and Fat specific
protein 27 (FSP27, also known as CIDEC in humans), have
been identified as important regulators of various meta-
bolic pathways [39]. Our previous work demonstrated that
CIDEA is expressed at high levels in BAT, whereas CIDEB
is expressed at high levels in liver. Mice with a deficiency
in both CIDEA and CIDEB have a higher energy expendi-
ture, enhanced insulin sensitivity and a resistance against
high-fat-diet-induced obesity and diabetes [40,41]. The
FSP27 protein was detected at high levels in WAT and at
moderate levels in BAT [42]. Furthermore, CIDE family
proteins have been shown to be associated with the lipid
droplet enriched fraction [42-45] and over-expression of
FSP27 promotes TAG storage [44]. FSP27-null mice have
a lean phenotype and are resistant to diet-induced obesity
[42,46]. In addition, the WAT of FSP27-deficient mice has
smaller lipid droplets as well as an increased mitochondrial
size and activity [42,46]. In particular, several genes that
are preferentially expressed in the BAT (UCP1, DIO2 and
CIDEA) and several regulatory factors (PPARa/g,P G C 1 )
are up-regulated in the WAT of FSP27-deficient mice [42].
Therefore, the WAT of FSP27 deficient mice appear to
adapt certain features similar to those found in BAT. The
regulatory pathways and the underlying mechanism of
FSP27-mediated transcriptional regulation in WAT and
BAT, however, remain unclear. Using microarray and
semi-quantitative real-time PCR (qPCR) analyses, we
demonstrated that the WAT of FSP27 or FSP27/leptin
deficient mice have markedly increased expression of
many BAT-selective genes and decreased expression of
WAT-selective genes. In addition, the expression levels of
many genes involved in mitochondrial oxidative phosphor-
ylation, lipolysis, fatty acid oxidation and the TCA cycle
were up-regulated in the WAT of FSP27-deficient mice,
which is consistent with their increased mitochondrial
activity and whole-body metabolism. In contrast, genes
involved in the classic complement pathway, extracellular
matrix remodeling and the TGF-b signaling pathway were
down-regulated in the WAT of FSP27-deficient mice.
Most importantly, the expression of regulatory factors that
activate the expression of BAT-selective genes was up-
regulated in the WAT of FSP27 deficient mice, providing a
molecular explanation for the increased expression of
BAT-selective genes and the acquisition of BAT-like prop-
erties in the WAT of FSP27-deficient mice.
Results
Alteration of the gene expression program in FSP27-
deficient mice as determined by microarray analysis
To determine the extent of the physiological changes
required to convert WAT into a BAT-like tissue and to
systematically analyze the transcriptional program of
WAT in FSP27-deficient mice, whole gene microarray
analysis was performed using Affymetrix oligonucleotide
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of wild-type and FSP27-deficient null mice. The expres-
sion of approximately 22,700 transcripts represented on
the Affymetrix mouse genome 430 2.0A microarray
chips was quantified in pooled WAT samples from five
each of the wild-type and FSP27-deficient mice. Dupli-
cate hybridizations were performed for each sample.
The genes were filtered according to the criteria of a
decrease ≥ 30% (2
-0.5)o ri n c r e a s e≥ 1.41-fold (2
0.5)i n
FSP27-deficient mice and consistency between the
duplicate experiments. After collapsing the dataset from
adjusted probes to symbols by GSEA, the expression
levels of 2,870 of 5,923 genes were changed in the WAT
of FSP27
-/- mice (48.5%). Among them, 1,037 genes
(36.1%) were increased, whereas 1,833 genes (63.9%)
were decreased. Notably, the 10 most highly elevated
genes (Table 1) include COX8b (40-fold increase),
ELOVL3 (12-fold increase), TR3 downstream gene 2
(NDG2, 8-fold increase), CIDEA (8-fold increase) and
cytochrome c oxidase subunit VIIa polypeptide
(COX7A1, 6-fold increase). Interestingly, COX8b (a
pseudogene), ELOVL3, CIDEA and COX7A1 have been
reported to be highly expressed in BAT but not WAT
[14,15]. Pyruvate dehydrogenase kinase isozyme 4
(PDK4), an enzyme involved in pyruvate metabolism
[47], and the lipid droplet binding protein LSDP5 were
also significantly increased. Overall, the 10 most up-
regulated genes in the WAT of FSP27-deficient mice
comprised mostly genes selectively expressed in BAT. In
contrast, the 10 most down-regulated genes involved in
diverse pathways, such as proteinase 3 (PRTN3) [48]
and retinitis pigmentosa GTPase regulator (RPGR) [49].
Another of the 10 most down-regulated proteins is
MEST, a protein expressed at high levels in WAT but
not in BAT [24].
The pathways that are altered in the WAT of FSP27-
deficient mice were determined by GSEA analysis. There
were extensive changes in the expression of genes involved
in many different metabolic pathways in the WAT of
FSP27-deficient mice. Most strikingly, the expression of
many proteins that localize to mitochondria were signifi-
cantly up-regulated (Figures 1A &1B and Additional file 1).
These genes are involved in the Krebs/TCA cycle (20 of 36
genes were up-regulated), the electron transport chain
(ETC, 68 of 110 genes were up-regulated), mitochondrial
fatty acid b-oxidation (12 of 17 genes were up-regulated)
and fatty acid degradation (13 of 33 genes were up-regu-
lated). These data are consistent with our previous obser-
vation that mitochondrial biogenesis and activity is
increased in the WAT of FSP27-deficient mice [42]. In
addition, the mRNA levels of many genes involved in gly-
colysis, gluconeogenesis, cholesterol biosynthesis, pan-
tothenate and CoA biosynthesis, heme biosynthesis,
nitrogen metabolism, ROS generation and the proteasome
pathway were significantly up-regulated (Figure 1A, and
Additional file 1). Microarray analysis also demonstrated
Table 1 The ten most up-regulated and ten most down-regulated genes in the WAT of FSP27-null mice
Name Gene Title Fold
Ten most upregulated genes
COX8B cytochrome c oxidase, subunit 8B pseudogene 40.06
ELOVL3 elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 3 11.9
NDG2 Nur77 downstream gene 2 8.35
CIDEA cell death-inducing DFFA-like effector a 8.22
COX7A1 cytochrome c oxidase subunit VIIa polypeptide 1 (muscle) 6.74
CA1 carbonic anhydrase I 6.72
PDK4 pyruvate dehydrogenase kinase, isozyme 4 5.83
CCRN4L CCR4 carbon catabolite repression 4-like (S. cerevisiae) 5.69
NAP1L5 nucleosome assembly protein 1-like 5 5.63
9530008L14RIK RIKEN cDNA 9530008L14 gene 5.59
Ten most downregulated genes
PRTN3 proteinase 3 (serine proteinase, neutrophil, Wegener granulomatosis autoantigen) -26.45
RPGR retinitis pigmentosa GTPase regulator -23.68
IGL-V1 immunoglobulin lambda chain, variable 1 -18.31
MEST mesoderm specific transcript homolog (mouse) -14.68
EAR11 eosinophil-associated, ribonuclease A family, member 11 -13.50
Tsr2 TSR2, 20S rRNA accumulation, homolog (S. cerevisiae) -13.15
NAP1L3 nucleosome assembly protein 1-like 3 -12.85
MS4A6D membrane-spanning 4-domains, subfamily A, member 6D -11.98
SFRP5 secreted frizzled-related protein 5 -11.88
TOP2A topoisomerase (DNA) II alpha 170 kDa -10.89
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as PGC1a, UCP1 and DIO2, were expressed at high levels
in the WAT of FSP27-deficient mice. Furthermore, factors
that inhibit BAT differentiation, such as RB/p107, were
down-regulated in the WAT of FSP27
-/- mice (Additional
file 2). These data are consistent with our previous obser-
vations [42].
The classic complement pathway, which plays an
important role in the initiation of the inflammatory
response, was significantly down-regulated in the WAT
of FSP27-deficient mice (6 of 16 genes were down-
regulated, including complement component genes
C1QA, C1QB, C1R, C1S, C2 and C6 (Additional file
2). Extracellular matrix proteins, including 15 members
of the collagen family in particular, were significantly
down-regulated (Additional file 3). Matrix metallopro-
teinase pathway (MMP) genes, including matrix metal-
lopeptidases 7, 14 and 16 and the tissue inhibitor of
metallopeptidase (TIMP) 1-4 (Additional file 3), were
also significantly down-regulated. Some genes involved
in the TGF-b pathway were also down-regulated
(Additional file 3). Furthermore, microarray analysis
also showed that IRS3, AKT2 and GLUT4, three genes
that are crucial for the regulation of insulin sensitivity,
were significantly up-regulated (Additional file 2).
These data are in accordance with our previous
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PANTOTHENATE_AND_COA_BIOSYNTHESIS 5/5/12
MITOCHONDRIAL_FATTY_ACID_BETAOSIXATION 12/12/27
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Figure 1 Dramatically altered transcriptional network in the WAT from FSP27-deficient mice by microarray analysis. A) The most
significant up-regulated and down-regulated pathways in the WAT of FSP27-null mice were identified using Gene Set Enrichment Analysis
(GSEA). The last number of each pathway represents the total number of genes in one gene set. The middle number represents the number of
genes with an altered expression pattern (using the criteria described above), and the first number represents the number of up-regulated or
down-regulated genes in the gene set. B) The pathways that were significantly up-regulated, as revealed by enrichment plot analysis, were the
Krebs-TCA cycle, the electron transport chain and the mitochondrial fatty acid b oxidation pathway. The denotation of the numbers in this figure
is as follows: The number of genes having a higher than 2
0.5-fold increase (the number of genes having a higher than 1-fold increase in
expression)/the number of genes with an altered expression pattern as determined by microarray in the WAT of Fsp27-/- mice (total number of
genes detected by the microarray)/total number of genes in a specific pathway.
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insulin sensitivity [42].
The profound increase in mitochondrial activity and
the up-regulation of mitochondrial proteins can likely be
attributed to the increased expression of PGC1, PPARa
and PPARg, as had been previously seen in the WAT of
FSP27-deficient mice. The gene expression profile in the
WAT of FSP27-deficient mice was compared with that of
differentiated brown fat cells that were PGC1a-a n d
PGC1b-deficient using Gene Set Enrichment Analysis
(GSEA) [50]. Among the 1,037 transcripts that were sig-
nificantly up-regulated in the WAT of FSP27-deficient
mice, a significant percentage of them (303, 29.2%) were
down-regulated in the PGC1a
-/- differentiated brown fat
cells expressing an siRNA specific for PGC1b knock-
down, suggesting that those 303 genes are downstream
targets of PGC1a and PGC1b (Figure 2). Comparison of
the gene expression profile in the WAT of FSP27-defi-
cient mice with that in PPARg2 over-expressing NIH3T3
cells and the WAT of PPARa-deficient mice, 265 of the
1,037 (25.6%) genes were significantly up-regulated in
the PPARg2 over-expressing NIH3T3 L1 cells, whereas
122 of the 1,037 (11.8%) genes were down-regulated in
the WAT of PPARa null mice (Figure 2). These data sug-
gest that FSP27 acts upstream to control the expression
of regulatory factors such as PGC1a and PPARa/g and
thus affect the expression of the downstream targets of
these regulatory factors, such as UCP1, DIO2 and
CIDEA.
Validation of the gene expression program in the WAT
and BAT of FSP27-deficient mice by quantitative real-time
PCR analysis
To validate our microarray data, qPCR analysis was used
to analyze the expression levels of representative genes
taken from a variety of pathways in the WAT and BAT of
FSP27- deficient mice. In a consistent manner, the expres-
sion levels of genes selectively expressed in BAT, including
COX8b, ELOVL3 and UCP1, were dramatically up-regu-
lated in the WAT of FSP27-deficient mice (85-, 140- and
35-fold increases, respectively; Figure 3A). The expression
levels of LSDP5 were also up-regulated (12-fold increase)
in FSP27-deficient WAT. Given that FSP27 is also
expressed in BAT, the expression levels of these genes
were then examined in the BAT of FSP27-deficient mice.
Surprisingly, there were similar levels of COX8b, LSDP5
and UCP1, but reduced expression of ELOVL3 in the
BAT of FSP27
-/- mice (Figure 3B). Because the expression
levels of many genes in various metabolic pathways are
affected by obesity, we generated leptin and FSP27 double
deficient mice (ob/ob/FSP27
-/-) and examined the expres-
sion levels of BAT-selective genes in the WAT of these
animals. Consistent with the previous observations, the
levels of COX8b, LSDP5 and ELOVL3 were significantly
elevated (125-, 30- and 230-fold increases) in the WAT of
ob/ob/FSP27 deficient mice compared with that of ob/ob
mice (Figure 3C), suggesting that the WAT of ob/ob/
FSP27
-/- mice also acquired certain BAT-like properties
despite the significantly higher lipid accumulation in these
obese mice.
The expression levels of genes selectively expressed in
the WAT were also examined by qPCR, which revealed
that the mRNA levels of MEST were significantly
reduced (approximately 10-fold lower compared with
that of wild-type mice, Figure 3D) in the WAT of
FSP27-deficient mice. qPCR on another WAT-selective
gene, resistin-related protein alpha (RETNLa), revealed
significantly lower mRNA levels for RETNLa (5-fold
decrease) in the WAT of FSP27-deficient mice, suggest-
ing that the expression of WAT-selective genes was sup-
pressed in FSP27-deficient WAT. As an endocrine
organ, WAT can secrete various adipocytokines and
inflammatory cytokines, such as adiponectin, leptin and
TNFa. There was an increase in adiponectin levels and
a reduction in leptin expression in the WAT of FSP27-
deficient mice, which is consistent with their lean and
insulin sensitive phenotypes (Figure 3D). No difference
in the expression of TNFa was observed between
wild-type and FSP27-deficient WAT (Figure 3D).
Figure 2 Comparison of the gene expression profile of FSP27-
deficient mouse white adipocytes with that of Pgc1a/Pgc1b
double deficient mouse brown adipocytes, the Ppara-deficient
mouse WAT or the cells over-expressing PPARg2. The up-
regulated genes (↑) in the white adipocytes of FSP27-null mice were
compared with the following: 1) the down-regulated genes (↓)i n
Pgc1a
-/- differentiated brown adipocytes expressing a siRNA specific
for Pgc1b (Pgc1a
-/- PGC1bsiRNA), 2) the down-regulated genes (↓)
in the WAT of Ppara
-/- mice (Ppara
-/-) or 3) the up-regulated genes
(↑) in the PPARg2 over-expressing NIH-3T3 cells (PPARg2). The
number in the over-lapping area represents the number of genes
that have conserved changes between the two cell types in the
comparison.
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Page 5 of 15Figure 3 Up-regulation of BAT-selective genes and down-regulation of WAT-selective genes in the WAT of FSP27-deficient mice.( A&B )
Relative expression levels of BAT-specific genes (COX8b, LSDP5, ELOVL3 and UCP1) in the WAT (A) and BAT (B) of wild-type (+/+) and FSP27-deficient
(FSP27
-/-) mice. (C) Expression levels of BAT-specific genes in the WAT of leptin-deficient (ob/ob)a n dleptin/FSP27 double-deficient (ob/ob/FSP27
-/-) mice.
(D&E ) Relative mRNA levels of WAT-selective genes (MEST, RETNLa, leptin, adiponectin and TNFa ) in the WAT of wild-type (+/+) and FSP27-null
(FSP27
-/-) mice, leptin-deficient (ob/ob)a n dleptin/FSP27 double-deficient (ob/ob/FSP27
-/-)m i c e( D) and in the BAT of wild-type (+/+) and FSP27-null
(FSP27
-/-)m i c e .( E). The bars represent the mean ± S.E.M. ***P < 0.001, **P < 0.01 and *P < 0.05. The expression levels of each gene were assessed by
semi-quantitative real-time PCR analysis. Three-month-old male mice were used in the analyses depicted in this and following figures unless
otherwise noted.
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ulation of adiponectin (10-fold decrease) were also
observed in the WAT of ob/ob/FSP27
-/- mice compared
with ob/ob mice. Surprisingly, the mRNA levels of
RETNLa were up-regulated in the WAT of ob/ob/
FSP27
-/- mice (2.5-fold increase, Figure 3E). The expres-
sion levels of MEST and RETNLa in the BAT of FSP27-
deficient mice were higher than those of wild-type mice
(3.2- and 1.75-fold increases for MEST and RETNLa,
respectively; Figure 3F). Previous reports showed that
ectopic expression of MEST markedly enlarged the size
of adipocytes and that its expression levels were posi-
tively correlated with larger adipocytes [24]. Increased
MEST expression is consistent with our previous obser-
vation that the BAT of FSP27-deficient mice had larger
lipid droplets and increased TAG accumulation [42].
The expression levels of resistin, another WAT-selective
gene, were similar in the BAT of both wild-type and
FSP27-deficient mice (Figure 3F).
The expression levels of genes involved in various
metabolic pathways, including lipid metabolism, uncou-
pling activity and mitochondrial electron transport chain
activity, were then examined. The expression levels of
genes involved in the fatty acid synthesis pathway, includ-
ing ACC1 (2.5-fold increase), ACC2 (10-fold increase),
and fatty acid synthase (FAS, 5-fold increase), were up-
regulated in the WAT of FSP27
-/- mice (Figure 4A). The
expression levels of genes involved in the mitochondrial
oxidative pathway (Cyto-C, COX4 and CPT1) and the
lipoprotein pathway, including the LDL receptor (LDLR,
4-fold increase) and Lipoprotein lipase (LPL, 2.6-fold
increase), were significantly up-regulated in the WAT of
FSP27-deficient mice (Figure 4A). Interestingly, UCP3, a
mitochondrial uncoupling protein that is homologous to
UCP1, is also significantly increased, suggesting an
increase in the uncoupling activity of the WAT of FSP27-
deficient mice. The expression levels of ACC1, FAS, HSL,
LDLR and COX 4 were also up-regulated in the BAT of
FSP27
-/- mice, whereas the mRNA levels for UCP3,
CPT1, LPL and adipsin were down-regulated in the BAT
of FSP27-deficient mice (Figure 4B).
To determine whether the expression levels of genes in
the classic complement and extracellular matrix remodel-
ing pathways were indeed reduced in the WAT of FSP27
-/-
mice, as indicated by the microarray analysis, the expres-
sion levels of complement factor 2 (C2), TIMP2/4, Fibro-
nectin1 (FN1), Collagen 3 alpha (COL3-a)a n d6a l p h a 1
(COL6-a1) were measured by qPCR. The levels of TIMP2
and TIMP4 were significantly reduced in the WAT of
FSP27-deficient mice (90% and 70% reduction for TIMP2
and TIMP4, respectively; Figure 4C). The levels of C2,
COL3-a and COL6-a1 were also reduced in the FSP27-
deficient WAT (70%, 90% and 50% reductions, respec-
tively; Figure 4C). Interestingly, lower levels of TIMP2
(70% lower) but higher levels of TIMP4 (7.8-fold higher)
and COL6-a1 (6 fold higher) were observed in the WAT
of ob/ob/FSP27-deficient mice (Figure 4D). No differences
in the levels of COL3a1, C2 or Fibronectin1 were observed
between ob/ob and ob/ob/FSP27
-/- mice (Figure 4D).
Given that lipid metabolism and mitochondrial activity
are controlled by many regulatory factors in WAT and
BAT, the expression levels of genes involved in the
TGF-b and cAMP pathways and of genes involved in
the regulation of adipogenesis were analyzed. While the
mRNA level of TGF-b1 was similar in the WAT of both
wild-type and FSP27-deficient mice, the mRNA levels
for TGF-b-receptor 2 (TGFb-R2) and TGFb-induced
protein (TGF-bi), an extracellular matrix molecule
induced by TGF-b that mediates the adhesion and
spreading of different cell types [51], were significantly
down-regulated in the WAT of FSP27-deficient mice
(40% and 50% reduction, respectively; Figure 5A). Inter-
estingly, SMAD4, a downstream mediator of the TGF-b
pathway, was significantly up-regulated (Figure 5A) in
the WAT of FSP27-deficient mice. The expression levels
o fS M A D 4w e r ea l s oi n c r e a s e di nt h eW A To fob/ob/
FSP27
-/- mice compared with that of ob/ob mice (Figure
5B), whereas no difference in the expression levels of
TGFb-R2 and TGF-bi was observed in the WAT of ob/
ob and ob/ob/FSP27
-/- mice (Figure 5B).
The expression levels of several regulatory factors,
including CEBPa and CEBPb, PREF-1, PRDM16, TR3
and components of the cAMP pathway, were further
analyzed. The expression levels of CEBPa and CEBPb,
which are transcriptional factors controlling adipocyte
differentiation and PPARg expression, were significantly
increased in the WAT of FSP27-deficient mice (Figure
5C), which is consistent with the increased PPARg
expression [42]. In contrast, the expression levels of
CEBPb were significantly reduced in the BAT of FSP27-
deficient mice (Figure 5D). Interestingly, the expression
of PREF-1, a unique preadipocyte marker, was reduced
in the WAT of FSP27-deficient mice, whereas its
expression level in the BAT was similar between wild-
type and FSP27
-/- mutant mice (Figure 5C &5D). The
expression levels of PRDM16 in the WAT of FSP27
-/-
mice were also significantly up-regulated compared with
that of wild-type mice. The expression of TR3 was
decreased in the BAT of FSP27
-/- mice (Figure 5D).
Importantly, there was a significantly increased expres-
sion of the b3-adrenergic receptor (b3-AR, 3.5-fold
increase, Figure 5C), the protein kinase A catalytic subu-
nit-a (PKAC-a, 1.8-fold increase) and the Gs alpha sub-
unit (Gs-a). The increased expression of genes involved
in the cAMP pathway could contribute to the activated
metabolism and increased UCP1 expression [42] found
in the WAT of FSP27-deficient mice. The expression
levels of CEBPa/b, PRDM16, b3-AR, PKAC-a and Gs-a
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Figure 4 Altered gene expressions in various metabolic pathways in the WAT of FSP27-deficient.( A&B ) Relative mRNA levels of genes
in various metabolic pathways in the WAT (A) and BAT (B) of wild-type (+/+) and FSP27-deficient (FSP27
-/-) mice. (C&D ) Relative mRNA levels
of genes in the classic complement and extracellular matrix remodeling pathways in the WAT of wild-type (+/+) and FSP27-null (FSP27
-/-) mice
(C) and of leptin-deficient (ob/ob) and leptin/FSP27 double-deficient (ob/ob/FSP27
-/-) mice (D). The bars represent the mean ± S.E.M. ***P < 0.001,
**P < 0.01 and *P < 0.05.
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Page 8 of 15were also up-regulated in the WAT of ob/ob/FSP27
-/-
mice (Figure 5E), which is consistent with the increased
expression of BAT-selective genes in these mice.
Furthermore, western blot analysis indicated that the
protein levels of CEBPb and b3-AR were significantly
increased (1.5- and 4-fold increases for CEBPb and b3-
AR, respectively; Figure 6), which is consistent with
their increased mRNA levels. The increased expression
of BAT-selective genes (CIDEA and COX8b), CEBPb
and b3-AR was also observed in the WAT of young
female and old male FSP27-deficient mice (Additional
file 4), suggesting that the acquisition of BAT-like prop-
erties in the WAT of FSP27-deficient mice occurs
regardless of sex or age. Interestingly, the increased
expression of PRDM16 was observed only in the WAT
of young male and female FSP27
-/- mice but not in the
WAT of old mice, suggesting that the regulation of
PRDM16 expression is age-dependent.
Discussion
Using microarray and qPCR analyses, we demonstrated
that FSP27 plays an important role in regulating mito-
chondrial oxidative phosphorylation, adipocyte differen-
tiation, lipolysis, fatty acid oxidation, the inflammatory
response and the extracellular matrix structure by con-
trolling extensive gene expression programs in both
WAT and BAT. Semi-quantitative real-time PCR ana-
lyses validated the reliability of the microarray data
(Additional file 5). Importantly, genes that are highly
enriched in BAT (e.g., COX8b, ELOVL3 and LSDP5)
were drastically up-regulated in the WAT of FSP27-defi-
cient mice. In contrast, WAT-enriched genes (e.g.,
MEST and RETNLa) were significantly down-regulated.
The expression levels of the set of WAT-selective genes
that were defined by Kajimura et al [30] were specifically
examined in our microarray analyses (Additional file 6).
A subset of these genes is down-regulated but others
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Page 9 of 15are up-regulated, suggesting that these genes are con-
trolled by different mechanisms. The BAT-like pheno-
type of FSP27-deficient WAT was further supported by
its significantly elevated expression of many genes
involved in the regulation of the TCA cycle, the electron
transport chain, uncoupling activity and the fatty acid
oxidation pathway, resulting in its conversion from an
energy storage organ to an energy consumption organ.
The increased expression of BAT-selective genes and
enhanced expression of genes involved in various meta-
bolic pathways in the WAT of FSP27
-/- mice are likely
due to the up-regulation of several regulatory factors: 1)
CEBPa and CEBPb, which activate PPARg expression
and promote adipogenesis; 2) PRDM16, which promotes
the differentiation of preadipocytes and myoblasts into
brown adipocytes; 3) PPARa/g and PGC1 and their
downstream target genes [42]; and 4) several genes in
the cAMP signaling pathway (e.g., b3-AR, PKAC-a and
Gs-a), which promote the conversion of white to brown
adipocytes by inducing UCP1 expression and mitochon-
drial activity in white adipose depots. Therefore, the up-
regulation of CEBPa/b and PRDM16 may act as an
initial step to increase the expression of PPARa/g and
PGC1 and promote adipocyte differentiation. The
increased expression of PPARa/g,P G C 1a n dt h ep r o -
teins involved in cAMP signaling in conjunction with
the reduced expression of Rb, P107 and RIP140 [42]
may act in concert to up-regulate genes specifically
expressed in BAT and genes involved in energy metabo-
lism, which in turn would promote the conversion of
WAT to a BAT-like tissue in FSP27-deficient mice.
The underlying mechanism responsible for the
increased expression of CEBPb and PRDM16 in the
WAT of FSP27-deficient mice is not understood. PREF-
1, which inhibits adipocyte differentiation via the upre-
gulation of SOX9, was down-regulated, likely resulting
in a reduction in the expression levels of SOX9 [52,53].
SOX9 can bind to the promoters for CEBPb and
CEBPδ, which would consequently suppress the activity
of those promoters resulting in the reduced expression
of PREF-1 and possibly SOX9 in the WAT of FSP27-
deficient mice. This cascade of events could, therefore,
lead to the up-regulation of CEBPb/δ. In addition, adi-
ponectin was up-regulated in the WAT of FSP27-defi-
cient mice (Fig. 3D). Adiponectin and its receptors have
been reported to induce extracellular Ca
2+ influx and
activate Ca
2+ /calmodulin-dependent protein kinase
kinase beta (CaMKKb), AMPK and SIRT1, resulting in
an increase in the expression of PGC-1a [54]. Therefore,
the up-regulation of adiponectin may contribute to the
increased levels of BAT-specific genes. In addition,
CEBPb has been shown to be phosphorylated and acti-
vated in response to an increase in the intracellular cal-
cium concentration, which was caused by the activation
of CaMKKb [55]. The mechanism responsible for the
transcriptional regulation of CEBPb and PRDM16 in the
WAT of FSP27 deficient mice remains to be clarified.
Our previous study indicated that the conversion of
WAT to a BAT-like tissue in FSP27-deficient mice
could be partially recapitulated in differentiated mouse
embryonic fibroblasts (MEFs) isolated from FSP27-defi-
cient mice. The differentiated FSP27-deficient MEFs
showed characteristics such as increased lipolysis, smal-
ler but multiple lipid droplets and reduced TAG storage.
More importantly, the FSP27-deficient MEFs had an
increased rate of fatty acid oxidation and higher expres-
sion levels of PGC1a,C I D E A ,U C P 1a n dC O X 4i nt h e
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Figure 6 Increased C/EBPb and μ3-AR protein levels in the
WAT of FSP27-null mice. (A) Western blot showing the increased
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mice (-/-) compared with those of wild type mice (+/+). b-actin was
used as a loading control. (B) The intensity of the indicated protein
bands in (A) was quantified using Quantity One software (BioRad,
USA) and used for statistical analyses. The western blot analyses
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Page 10 of 15presence of T3 [42]. The relative expression levels of
these BAT-selective genes in differentiated FSP27-defi-
cient MEFs, however, were not as high as those seen in
the WAT of FSP27-deficient mice [42]. For example, the
mRNA levels of CIDEA and UCP1 are similar between
wild-type and FSP27
-/- MEFs, and the level of COX4
was 1.5-fold higher in FSP27
-/- MEFs compared with
that of wild-type cells. In the FSP27-deficient WAT, in
contrast, mRNA levels of these three genes were 2.6-,
16.8- and 2.3-fold increased, respectively [42]. In addi-
tion, there was no difference in the expression of BAT-
selective genes and mitochondrial activity between dif-
ferentiated wild-type and FSP27 knock-down 3T3-L1
cells (data not shown). In differentiated FSP27 knock-
down 3T3-L1 cells, Keller et al. also observed no differ-
ence in the expression of BAT-selective genes [56]. The
discrepancy between the WAT of FSP27-deficient mice
and in vitro cultured FSP27 deficient adipocytes may be
due to the lack of crucial extracellular factors that coop-
e r a t ew i t hF S P 2 7t od e t e r m i n et h eB A Ti d e n t i t yi nc u l -
tured adipocytes. Alternatively, the commitment to the
transition of WAT into BAT-like tissue in FSP27
-/- mice
may occur before differentiation at the precursor stage.
Further experiments will be needed to distinguish these
possibilities.
Interestingly, there was a significantly reduced expres-
sion of genes involved in TGF-b signaling in the WAT
of FSP27
-/- mice. Because activation of the TGF-b sig-
naling pathway was shown to inhibit adipocyte differen-
tiation [57], reduced TGF-b signaling may further
enhance white adipocyte differentiation in FSP27-defi-
cient mice. The classic complement pathway, which
plays a key role in the initiation of the inflammatory
response in adipose tissue under obese and insulin-resis-
tant conditions [58], was significantly down-regulated in
the WAT of FSP27-deficient mice, implicating a reduced
inflammatory response in the WAT. These data were
also consistent with our previous observation that
FSP27-deficient mice had improved insulin sensitivity
and a lean phenotype [42,46]. Finally, a significantly
reduced expression of collagen family proteins, MMPs
and TIMPs, which all play key roles in determining the
three-dimensional (3-D) structure of the WAT and in
controlling extracellular matrix (ECM) remodeling
[59-62], was observed in the WAT of FSP27-deficient
mice. These data suggest that the 3-D structure and, in
particular, the ECM structure of FSP27-deficient WAT
is different from that of wild-type mice, which may be
reflected in its reduced adipocyte size and reduced
inflammatory response. As main components of extra-
cellular matrix, the levels of collagen family proteins are
generally up-regulated in the adipose tissue of diabetic
mice [60]. In addition, animals with a disruption of col-
lagen VI, a predominant collagen in adipose tissue, have
larger adipocytes but improved insulin sensitivity [62].
The decreased ECM pathway may contribute to the
reduced lipid storage in white adipocytes and the
improved insulin sensitivity in FSP27-deficient mice.
Using leptin/FSP27 double deficient mice as a model
system, the expression of BAT-selective genes and regu-
latory factors was analyzed under the conditions of
FSP27 deficiency and obesity. BAT-selective genes and
key metabolic regulators (e.g., CEBPa/b and PRDM16)
and members of the cAMP signaling pathway (e.g., b3-
AR, PKAC-a and Gs-a) were all up-regulated in the
FSP27/leptin double deficient mice, which is consistent
with that seen under the condition of FSP27 deficiency
alone. Thus, white adipocytes in FSP27 and leptin dou-
ble deficient mice also acquire BAT-like properties and
become an energy consuming organ. The expression
profile of the genes involved in TGF-b signaling, extra-
cellular matrix remodeling and the classic complement
pathway in the WAT of ob/ob/FSP27
-/- mice, however,
was different from that of FSP27 deficient mice. This
observation indicated that gene expression in these
pathways in obese animals requires the cooperative
action of FSP27 and other extrinsic factors.
Paradoxically, the gene expression profile in the BAT
of FSP27-deficient mice was dramatically different from
that of the FSP27-deficient WAT based on the following
observations: 1) in the BAT of FSP27-deficient mice,
there was a significantly increased expression of WAT-
selective markers (MEST and RETNLa)t h a ta r en o r -
mally suppressed by the expression of PRDM16; 2) the
expression of several mitochondrial genes (UCP3 and
CPT1) was down-regulated; and 3) the expression levels
of regulatory factors including CEBPb and TR3 were
reduced in the BAT of FSP27-deficient mice, whereas
the expression of components in the cAMP pathway
was similar to that of wild-type mice. The mechanism
by which the expression profile of BAT of FSP27-defi-
cient mice differs from that of WAT remains unclear.
G i v e nt h a tC I D E Ai se x p r e s s e da tah i g hl e v e li nB A T ,
it may replace FSP27 and perform some of the functions
of FSP27. Further analysis using CIDEA/FSP27 double
knock-out mice will be needed to address the role of
these individual genes in BAT.
Conclusions
Overall, our data suggest that FSP27 acts as a crucial
factor that controls the expression of genes involved in
various regulatory and metabolic pathways in WAT and
BAT. FSP27 deficiency results in the up-regulation of
regulatory factors that promote the activation of BAT-
selective genes and genes involved in energy expenditure
processes such as mitochondrial activity. The coordi-
nated regulation of such profound transcriptional net-
works that affect multiple metabolic and signaling
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Page 11 of 15pathways is an interesting property of FSP27-deficient
mice. Although the precise mechanism by which FSP27
regulates these gene expression programs is not clear,
our study strongly suggests that FSP27 is an important
molecular determinant in controlling gene expression
networks and in maintaining white adipocyte identity.
Methods
Animal breeding and maintenance
FSP27-deficient (FSP27
-/-) mouse breeding and mainte-
nance were essentially performed as described previously
[42]. The Leptin/FSP27 double deficiency (ob/ob/
FSP27
-/-) mice were generated by crossing FSP27
-/- mice
with heterozygous ob/+ mice (B6.V-Lepob/J) in a
C57BL/6 background that were obtained from The Jack-
son Laboratories (Bar Harbor, ME). Genotyping for
FSP27 and leptin deficiency in the offspring was per-
formed as described previously [42,63]. The ob/ob/
FSP27
-/- littermates were compared with their leptin
deficient (ob/ob) littermates. The FSP27
-/- and ob/ob/
FSP27
-/- mice were fed a normal chow diet (5053, Pico-
Lab Rodent Diet 20). Mouse experiments were carried
out in the animal facility in the School of Life Sciences,
Tsinghua University. Mouse handling procedures were
in accordance with the Responsible Care and Use of
Laboratory Animals (RCULA) guidelines set by Tsin-
ghua University. All research and experimental protocols
involving mice were reviewed and approved by the ani-
mal research committee of Tsinghua University.
RNA extraction, RT-PCR, semi-quantitative real-time
RT-PCR and microarray analyses
Gonadal WAT or interscapular BAT from 3- or 9-
month-old mice were dissected and quickly frozen in
liquid nitrogen upon sacrifice and then stored at -80°C
for subsequent total RNA extraction. Total RNA from
gonadal WAT or interscapular BAT was isolated indivi-
dually using the TRIzol reagent (Invitrogen, USA) and
quantified spectrophotometrically at 260/280 nm. The
integrity of all RNA samples was evaluated on a 1%
agarose gel, and all RNA samples were found to be pure
with no degradation caused by the isolation procedure.
For semi-quantitative real-time RT-PCR (qPCR) analysis,
RNA isolated from four individual animals for each gen-
otype was used for independent qPCR analysis. The
first-strand cDNAs were synthesized from 2 μgo ft o t a l
RNA in a total volume of 20 μl using oligo-(dT)20 pri-
mers and the Superscript III RT kit at 50°C for 60 mins
according to the manufacturer’s protocol (Invitrogen,
USA). The reaction was inactivated by incubating the
reaction mixture at 70°C for 15 minutes, followed by the
removal of RNA complementary to the cDNA with 1 μl
(2 units) of E. coli RNase H (Invitrogen, USA) at 37°C
for 20 minutes. The cDNA samples were then diluted
with sterile deionized water to a total volume of 200 μl,
and 2 μl was used for each qPCR reaction.
qPCR analysis was performed using the ABI SYBR
Green PCR Master Mix in the MX3000P real-time PCR
system (Stratagene, USA) according to the manufacturer’s
protocol. Primer sequences, annealing temperatures and
the size of each amplified PCR product are given in Addi-
tional file 7. A BLAST search against the mouse genome
using the electronic PCR program from the NCBI Gen-
ome Database of the primer pairs confirmed that no geno-
mic or pseudogene PCR products would be amplified.
b-actin was used as an internal control for the qPCR ana-
lyses. To validate its reliability during the analyses, another
common internal control, cyclophilin (an ER specific pro-
tein), was used to evaluate the expression levels of b-actin.
Its expression was similar between wild-type and FSP27-
deficient mice. In addition, the expression levels of repre-
sentative genes (leptin and Collagen-6a1) using cyclophi-
lin as the internal control were similar to those using b-
actin as the internal control, indicating that b-actin was a
reliable internal control for the normalization of our qPCR
results (Additional file 8).
For microarray analyses, equal amounts of total RNA
from five pairs of three-month-old male FSP27-deficient
mice were combined to form RNA pools (total amount of
45 μg). Affymetrix gene chips (Mouse Genome 430 2.0A
arrays, Affymetrix, USA) were used for hybridization and
data collection. The protocol was performed by the Micro-
array Facility at the Institute of Molecular and Cell Biology
in Singapore. The microarray data were processed with the
Affymetrix GeneChip Operating Software (GCOS) and
submitted to the GEO repository for the Series record
(GSE22693). The gene set enrichment analysis (GSEA)
was performed as previously described [64]. The microar-
r a yd a t af r o mPPARa-deficient WAT, PGC1a/PGC1b
double-deficient brown fat cells and PPARg2 over-expres-
sing NIH3T3 cells were extracted from the Gene Expres-
sion Omnibus with the accession numbers GSE2131[65],
GSE5042 [50] and GSE2192 [66], respectively.
Western blot analysis
Cell lysates from the WAT of wild type and FSP27
-/-
3-month-old male mice were obtained by homogenizing
the tissues in RIPA buffer (20 mM HEPES-KOH pH 7.5,
150 mM NaCl, 1 mM EDTA, 10% Glycerol, 0.5%
sodium deoxycholate, 1% NP40, 0.1% SDS and protease
inhibitor) and subsequently used for western blot analy-
sis as previously described [36]. Antibodies against
b-actin (Sigma, USA) as well as b3-AR and CEBPb
(Santa Cruz, USA) were used for the western blot ana-
lyses. Protein bands were visualized by an Enhanced
Chemiluminescence detection system and quantified by
densitometry analysis using Quantity One (Bio-Rad,
USA). The experiments were performed in triplicate.
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Page 12 of 15Statistical analysis
All data were presented as means ± S.E.M. Differences
between groups were assessed by a two-tailed, non-
paired or paired Student’st - t e s tu s i n gt h eG r a p hP a d
Prism statistics software (GraphPad Software Inc.)
Additional material
Additional file 1: Significantly upregulated pathways in Fsp27-
deficient WAT. Genes are grouped according to their function and
listed in the alphabetical order under each heading. The last number
represents the total genes in one gene set. The middle is the changed
(criteria is designated as fold change between wildtype and Fsp27 -/-
mice is more than ± 1.41) gene number,
Additional file 2: Factors that inhibit BAT differentiation were
down-regulated in the WAT of FSP27-/- mice.
Additional file 3: Significantly down-regulated pathways in the WAT
of Fsp27-null mice. Genes are grouped according to their function and
listed in alphabetical order under each heading. The last number
represents the total number of genes in one gene set. The middle
number represents the number of genes with an altered expression
pattern (criteria designated as a fold-change between wildtype and
Fsp27 -/- mice of more than ± 1.41). The first number represents the
number of upregulated or downregulated genes in that gene set.
Additional file 4: Expression of BAT-selective genes and the major
regulators in the WAT of young female or old male FSP27 deficient
mice.( A&B ) Relative mRNA levels of BAT-specific genes and the main
regulatory factors in the WAT of three-month-old female (A) or nine-
month-old male (B) wild type (+/+) and FSP27 null (FSP27
-/-) mice.
Additional file 5: Comparison of microarray and qPCR analyses.A
total of 52 genes were analyzed by qPCR in the current study and a
previous report [Ref [42]]. Among these 52 validated genes, 34 were
determined to be up- or down-regulated by microarray analysis, and 30 of
those 34 genes (88%) were consistently validated by qPCR. The increased
sensitivity of qPCR allowed the detection of alterations in the expression
levels of low abundant gene such as PREF-1. Only Smad4 expression
showed opposite results in the two analyses. N/A: not available; NC: no
change according to the given criteria; +: increase; -: decrease.
Additional file 6: Altered profiles of WAT-selective genes in FSP27-
deficient WAT. The list of WAT-selective genes is taken from Reference
30. These genes were determined to be differentially expressed in FSP27-
deficient WAT by microarray analysis
Additional file 7: Primer sequences for the genes involved in the
qPCR analysis.
Additional file 8: Validation of b-actin as a reliable internal control
for the qPCR data analyses.( A) Relative mRNA levels of leptin,
Collagen 6 alpha1 (COL6-a1) and cyclophilin using b-actin as an internal
control for the normalization of qPCR results. Reduced levels of leptin
and COL6-a1 expression but a similar level of cyclophilin expression
were observed in the WAT of FSP27 null mice (FSP27
-/-) compared with
those of wild type mice (+/+). (B) Relative mRNA levels of leptin, COL6-
a1 and b-actin using cyclophilin as an internal control for the
normalization of qPCR results. Reduced levels of leptin and COL6-a1
expression but a similar level of b-actin expression in the WAT of FSP27
null mice (FSP27
-/-) compared with those of wild type mice (+/+). Both
data sets are consistent and validate the use of b-actin as a reliable
internal control for qPCR analysis.
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